Literature DB >> 23221422

Role of kinase suppressor of ras-1 in lipopolysaccharide-induced acute lung injury.

Xiang Li1, Erich Gulbins, Yang Zhang.   

Abstract

Kinase suppressor of ras-1 (Ksr1) has been recently shown to be a central signaling molecule in the host response to Pseudomonas aeruginosa infections in the lung. Ksr1 functions to regulate the release of nitric oxide (NO)-radicals upon P. aeruginosa infections. Ksr1 also enhances Raf-1/MEK/ERK signaling and is involved in a variety of cellular responses, including cell differentiation, proliferation, and apoptosis. Here, we investigated whether Ksr1 is involved in the host immune response to lipopolysaccharide (LPS), one of the major components of gram-negative bacteria, in the lung. To this end, we induced an acute lung injury in wild type and Ksr1-deficient mice by intratracheal instillation of LPS. We found that LPS-induces acute lung injury, as characterized by cytokine expression, neutrophil infiltration and protein extrusion in wildtype mice. Ksr1-deficient mice showed a very similar reaction to LPS as the wildtype mice. In freshly isolated alveolar macrophages from wild type and Ksr1-deficient mice, LPS increased ERK activation, nuclear translocation of NFĸB and expression of inflammatory cytokines and chemokines in a similar pattern. Inhibition of Src or Raf-1 blocked LPS-induced ERK activation. Taken together, these findings indicate that Ksr1 plays a dispensable role in LPS-induced ERK activation in alveolar macrophages and does not contribute to the development of acute lung injury in the LPS model.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23221422      PMCID: PMC3758749          DOI: 10.1159/000341468

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  23 in total

Review 1.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions.

Authors:  W Kolch
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

2.  Kinase suppressor of Ras couples Ras to the ERK cascade during T cell development.

Authors:  Micheline N Laurent; Danny Maria Ramirez; José Alberola-Ila
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

Review 3.  Macrophages and polymorphonuclear neutrophils in lung defense and injury.

Authors:  Y Sibille; H Y Reynolds
Journal:  Am Rev Respir Dis       Date:  1990-02

4.  Kinase suppressor of Ras is ceramide-activated protein kinase.

Authors:  Y Zhang; B Yao; S Delikat; S Bayoumy; X H Lin; S Basu; M McGinley; P Y Chan-Hui; H Lichenstein; R Kolesnick
Journal:  Cell       Date:  1997-04-04       Impact factor: 41.582

Review 5.  KSR: a novel player in the RAS pathway.

Authors:  J Downward
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

6.  Kinase suppressor of Ras-1 protects against pulmonary Pseudomonas aeruginosa infections.

Authors:  Yang Zhang; Xiang Li; Alexander Carpinteiro; Jeremy A Goettel; Matthias Soddemann; Erich Gulbins
Journal:  Nat Med       Date:  2011-02-06       Impact factor: 53.440

Review 7.  Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group.

Authors:  Michael A Matthay; Guy A Zimmerman; Charles Esmon; Jahar Bhattacharya; Barry Coller; Claire M Doerschuk; Joanna Floros; Michael A Gimbrone; Eric Hoffman; Rolf D Hubmayr; Mark Leppert; Sadis Matalon; Robert Munford; Polly Parsons; Arthur S Slutsky; Kevin J Tracey; Peter Ward; Dorothy B Gail; Andrea L Harabin
Journal:  Am J Respir Crit Care Med       Date:  2003-04-01       Impact factor: 21.405

8.  Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo.

Authors:  AnhCo Nguyen; W Richard Burack; Jeffrey L Stock; Robert Kortum; Oleg V Chaika; Maryam Afkarian; William J Muller; Kenneth M Murphy; Deborah K Morrison; Robert E Lewis; John McNeish; Andrey S Shaw
Journal:  Mol Cell Biol       Date:  2002-05       Impact factor: 4.272

9.  Caspase-1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury.

Authors:  Sarah J Rowe; Lucy Allen; Victoria C Ridger; Paul G Hellewell; Moira K B Whyte
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

10.  Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice.

Authors:  José Lozano; Rosie Xing; Zhenzi Cai; Heather L Jensen; Carol Trempus; Willie Mark; Ron Cannon; Richard Kolesnick
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

View more
  5 in total

1.  Fraxinol attenuates LPS-induced acute lung injury by equilibrating ACE-Ang II-AT1R and ACE2-Ang (1-7)-Mas and inhibiting NLRP3.

Authors:  Yan Wu; Xin Yang; Yuanyuan Ju; Fei Zhao
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

2.  Instigation of endothelial Nlrp3 inflammasome by adipokine visfatin promotes inter-endothelial junction disruption: role of HMGB1.

Authors:  Yang Chen; Ashley L Pitzer; Xiang Li; Pin-Lan Li; Lei Wang; Yang Zhang
Journal:  J Cell Mol Med       Date:  2015-08-20       Impact factor: 5.310

3.  Systemic blockade of P2X7 receptor protects against sepsis-induced intestinal barrier disruption.

Authors:  Xiuwen Wu; Jianan Ren; Guopu Chen; Lei Wu; Xian Song; Guanwei Li; Youming Deng; Gefei Wang; Guosheng Gu; Jieshou Li
Journal:  Sci Rep       Date:  2017-06-29       Impact factor: 4.379

4.  Endothelial NLRP3 inflammasome activation and arterial neointima formation associated with acid sphingomyelinase during hypercholesterolemia.

Authors:  Saisudha Koka; Min Xia; Yang Chen; Owais M Bhat; Xinxu Yuan; Krishna M Boini; Pin-Lan Li
Journal:  Redox Biol       Date:  2017-06-15       Impact factor: 11.799

5.  Ginsenoside Rh2 Ameliorates Lipopolysaccharide-Induced Acute Lung Injury by Regulating the TLR4/PI3K/Akt/mTOR, Raf-1/MEK/ERK, and Keap1/Nrf2/HO-1 Signaling Pathways in Mice.

Authors:  Yung-Hung Hsieh; Jeng-Shyan Deng; Yuan-Shiun Chang; Guan-Jhong Huang
Journal:  Nutrients       Date:  2018-09-01       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.